HEOR

News

Appeal finds NICE must reconsider Alzheimer's drugs

Lilly and Eisai's bid to secure NHS coverage of their Alzheimer's therapies has entered a new phase, after an appeal of last year's rejection by NICE.

News

First MHRA/NICE aligned guidance due in June

The aligned regulatory pathway for UK drugs regulator MHRA and reimbursement authority NICE gets underway on 1st April.

News

NHS cleared to use Astellas' non-hormonal menopause drug

Around half a million women will soon be able to access Astellas' Veoza treatment for symptoms like hot flushes associated with menopause.

News

NICE says no to Genmab cervical cancer therapy

Genmab's recently approved therapy for relapsed cervical cancer has been turned down for NHS use in initial NICE guidance.

News

Joy as NICE changes tack on first NHS vitiligo treatment

NHS patients in England with vitiligo will soon be able to access Incyte's Opzelura, the first drug shown to reverse the skin-lightening disorder.

News

The word Diabetes surrounded by tablets and syringes

NICE backs changes to NHS' diabetes care pathway

New guidance from NICE on type 2 diabetes management will shake up NHS treatment, with wider use of both SGLT2 inhibitors and GLP-1 agonists.

Appeal finds NICE must reconsider Alzheimer's drugs

First MHRA/NICE aligned guidance due in June

NHS cleared to use Astellas' non-hormonal menopause drug

NICE says no to Genmab cervical cancer therapy

Joy as NICE changes tack on first NHS vitiligo treatment

NICE backs changes to NHS' diabetes care pathway

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

HEOR

Editor's Picks